Abstract | OBJECTIVES: BACKGROUND: The use of FFR to guide PCI has been well established for patients with SA. Its use in patients with UA or NSTEMI has not been investigated prospectively. METHODS: In the FAME (Fractional flow reserve versus Angiography for Multivessel Evaluation) study 1,005 patients with multivessel disease amenable to PCI were included and randomized to either angiography-guided PCI of all lesions ≥50% or FFR-guided PCI of lesions with an FFR ≤0.80. Patients admitted for UA or NSTEMI with positive troponin but total creatine kinase <1,000 U/l were eligible for inclusion. We determined 2-year major adverse cardiac event rates of these patients and compared it with stable patients. RESULTS: Of 1,005 patients, 328 had UA or NSTEMI. There was no evidence for heterogeneity among the subgroups for any of the outcome variables (all p values >0.05). Using FFR to guide PCI resulted in similar risk reductions of major adverse cardiac events and its components in patients with UA or NSTEMI, compared with patients with SA (absolute risk reduction of 5.1% vs. 3.7%, respectively, p = 0.92). In patients with UA or NSTEMI, the number of stents was reduced without increase in hospital stay or procedure time and with less contrast use, in similarity to stable patients. CONCLUSIONS: The benefit of using FFR to guide PCI in multivessel disease does not differ between patients with UA or NSTEMI, compared with patients with SA.
|
Authors | Jan-Willem E M Sels, Pim A L Tonino, Uwe Siebert, William F Fearon, Marcel Van't Veer, Bernard De Bruyne, Nico H J Pijls |
Journal | JACC. Cardiovascular interventions
(JACC Cardiovasc Interv)
Vol. 4
Issue 11
Pg. 1183-9
(Nov 2011)
ISSN: 1876-7605 [Electronic] United States |
PMID | 22115657
(Publication Type: Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. |
Topics |
- Aged
- Angina, Unstable
(diagnostic imaging, mortality, physiopathology, therapy)
- Angioplasty, Balloon, Coronary
(adverse effects, instrumentation, mortality)
- Chi-Square Distribution
- Coronary Angiography
- Coronary Artery Disease
(diagnostic imaging, mortality, physiopathology, therapy)
- Female
- Fractional Flow Reserve, Myocardial
- Heart Diseases
(etiology)
- Humans
- Kaplan-Meier Estimate
- Length of Stay
- Male
- Middle Aged
- Myocardial Infarction
(diagnostic imaging, mortality, physiopathology, therapy)
- Predictive Value of Tests
- Prospective Studies
- Risk Assessment
- Risk Factors
- Stents
- Treatment Outcome
|